In this issue:
Tildrakizumab and metabolic syndrome status in psoriasis
Probiotics in patients with psoriasis
Insufficient responders to anti-TNF therapies
Different wage earnings between patients on biologics vs oral therapies
Smart identification of psoriasis by convolutional neural networks
Observer-independent assessment of psoriasis using machine learning
Patient characteristics and systemic treatments for psoriasis
Tattoo complications in treated and non-treated psoriatic patients
Phototherapy achieves significant cost savings
Please login below to download this issue (PDF)